Midodrine as adjunctive support for treatment of refractory hypotension in the intensive care unit: a multicenter, randomized, placebo controlled trial (the MIDAS trial)

BACKGROUND: Patients admitted to intensive care units (ICU) are often treated with intravenous (IV) vasopressors. Persistent hypotension and dependence on IV vasopressors in otherwise resuscitated patients lead to delay in discharge from ICU. Midodrine is an oral alpha-1 adrenergic agonist approved...

Descripción completa

Detalles Bibliográficos
Autores principales: Anstey, Matthew H., Wibrow, Bradley, Thevathasan, Tharusan, Roberts, Brigit, Chhangani, Khushi, Ng, Pauline Yeung, Levine, Alexander, DiBiasio, Alan, Sarge, Todd, Eikermann, Matthias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5361788/
https://www.ncbi.nlm.nih.gov/pubmed/28327122
http://dx.doi.org/10.1186/s12871-017-0339-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5361788/
https://www.ncbi.nlm.nih.gov/pubmed/28327122
http://dx.doi.org/10.1186/s12871-017-0339-x

Ejemplares similares